Lindsey Draper, MD

Dr. Lindsey Draper is a medical oncologist who specializes in caring for patients with recurrent ovarian cancer. Her role includes providing chemotherapy and immunotherapy, as well as evaluating and offering clinical trial participation (opportunities to receive experimental treatments) to patients who meet a study's criteria.

Draper is passionate about developing new immunotherapies that can give patients with ovarian cancer and other solid tumors more effective and less toxic treatment options. Her research has included studying tumor-infiltrating lymphocyte (TIL) therapy for patients with advanced cervical cancer at the National Cancer Institute, which led to clinical trials in which some patients had a complete response (all signs of cancer disappeared) after a single infusion and remain disease-free more than a decade later. She continues this work in a UCSF research program focused on genetically modifying TILs (a type of white blood cell) from ovarian cancers to develop treatments. She has garnered honors for her research, including becoming a Parker Scholar with the Parker Institute for Cancer Immunotherapy, earning a Symbiont Seed Grant from the Gladstone-UCSF Institute of Genomic Immunology, and receiving the Conquer Cancer Young Investigator Award from the American Society of Clinical Oncology.

Draper earned her medical degree at the University of Maryland. She completed a residency in internal medicine at the Mount Sinai Hospital and a fellowship in medical oncology at UCSF. She also completed a physician-scientist fellowship at the Chan Zuckerberg Biohub. She is an associate member of the American Association for Cancer Research and a member of the Society for Immunotherapy of Cancer and American Society of Clinical Oncology.